Fresenius Seco Adr Stock Fundamentals
| FREA Stock | EUR 8.10 0.05 0.61% |
FRESENIUS SECO ADR fundamentals help investors to digest information that contributes to FRESENIUS SE+CO's financial success or failures. It also enables traders to predict the movement of FRESENIUS Stock. The fundamental analysis module provides a way to measure FRESENIUS SE+CO's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to FRESENIUS SE+CO stock.
FRESENIUS |
FRESENIUS SECO ADR Company Profit Margin Analysis
FRESENIUS SE+CO's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current FRESENIUS SE+CO Profit Margin | 0.04 % |
Most of FRESENIUS SE+CO's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, FRESENIUS SECO ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, FRESENIUS SECO ADR has a Profit Margin of 0.0402%. This is 100.36% lower than that of the Healthcare sector and 100.79% lower than that of the Medical Care industry. The profit margin for all Germany stocks is 103.17% lower than that of the firm.
FRESENIUS SECO ADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining FRESENIUS SE+CO's current stock value. Our valuation model uses many indicators to compare FRESENIUS SE+CO value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across FRESENIUS SE+CO competition to find correlations between indicators driving FRESENIUS SE+CO's intrinsic value. More Info.FRESENIUS SECO ADR is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.37 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for FRESENIUS SECO ADR is roughly 2.72 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the FRESENIUS SE+CO's earnings, one of the primary drivers of an investment's value.FRESENIUS Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses FRESENIUS SE+CO's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of FRESENIUS SE+CO could also be used in its relative valuation, which is a method of valuing FRESENIUS SE+CO by comparing valuation metrics of similar companies.FRESENIUS SECO is currently under evaluation in profit margin category among its peers.
FRESENIUS Fundamentals
| Return On Equity | 0.0793 | |||
| Return On Asset | 0.0292 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.09 % | |||
| Shares Outstanding | 2.25 B | |||
| Price To Earning | 12.47 X | |||
| Revenue | 40.16 B | |||
| Gross Profit | 10.26 B | |||
| EBITDA | 5.35 B | |||
| Net Income | 1.86 B | |||
| Cash And Equivalents | 1.46 B | |||
| Cash Per Share | 0.66 X | |||
| Total Debt | 26.88 B | |||
| Debt To Equity | 105.90 % | |||
| Current Ratio | 1.08 X | |||
| Book Value Per Share | 9.49 X | |||
| Cash Flow From Operations | 3.98 B | |||
| Earnings Per Share | 0.72 X | |||
| Number Of Employees | 319.69 K | |||
| Beta | 1.12 | |||
| Market Capitalization | 15.17 B | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 0.93 % | |||
| Last Dividend Paid | 0.92 |
About FRESENIUS SE+CO Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze FRESENIUS SECO ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FRESENIUS SE+CO using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FRESENIUS SECO ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hhe, Germany. FRESENIUS SECO operates under Medical Care classification in Germany and is traded on Frankfurt Stock Exchange. It employs 288459 people.
Currently Active Assets on Macroaxis
Other Information on Investing in FRESENIUS Stock
FRESENIUS SE+CO financial ratios help investors to determine whether FRESENIUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in FRESENIUS with respect to the benefits of owning FRESENIUS SE+CO security.